Kevin M. Krause
- Molecular Medicine top 0.2%
- Pharmacology top 0.5%
- Infectious Diseases top 2%
- Molecular Biology top 10%
- Epidemiology top 5%
- Co-authors
- Alisa W. SerioLynn ConnollyTimothy R. KaneBret M. BentonTiffany R. KeepersMariana CastanheiraDmitri DebabovKoné Kaniga
- Topics
- Antibiotic Resistance in Bacteria (38 papers)Antibiotics Pharmacokinetics and Efficacy (28 papers)Antimicrobial Resistance in Staphylococcus (18 papers)
- Journals
- New England Journal of MedicineJournal of the American Chemical SocietyNature Reviews Drug Discovery
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Kevin M. Krause
77 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Molecular Medicine 1.4k
- Pharmacology 1.2k
- Infectious Diseases 924
- Molecular Biology 809
- Epidemiology 748
Countries citing papers authored by Kevin M. Krause
This map shows the geographic impact of Kevin M. Krause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin M. Krause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin M. Krause more than expected).
Fields of papers citing papers by Kevin M. Krause
This network shows the impact of papers produced by Kevin M. Krause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin M. Krause. The network helps show where Kevin M. Krause may publish in the future.
Co-authorship network of co-authors of Kevin M. Krause
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin M. Krause. A scholar is included among the top collaborators of Kevin M. Krause based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin M. Krause. Kevin M. Krause is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 2 | |
| 5 | 15 | |
| 6 | 4 | |
| 7 | 59 | |
| 8 | 21 | |
| 9 | 23 | |
| 10 | 39 | |
| 11 | 19 | |
| 12 | Aminoglycosides: An Overviewbreakdown → | 714 |
| 13 | 13 | |
| 14 | 8 | |
| 15 | 19 | |
| 16 | Activity of Telavancin Against Gram-Positive Isolates from Phase 3 Studies of Hospital-Acquired Pneumonia (ATTAIN) | 1 |
| 17 | 36 | |
| 18 | 126 | |
| 19 | Relating Venous Gas Emboli (VGE) Scores to Altitude Decompression Sickness (DCS) Symptoms | 1 |
| 20 | 16 |
About Kevin M. Krause
Kevin M. Krause is a scholar working on Molecular Medicine, Pharmacology and Energy Engineering and Power Technology, having authored 80 papers that have together received 3.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (38 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers) and Antimicrobial Resistance in Staphylococcus (18 papers). The work is most often cited by research in Molecular Medicine (1.4k citations), Applied Microbiology and Biotechnology (335 citations) and Clinical Biochemistry (527 citations). Kevin M. Krause has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Alisa W. Serio, Lynn Connolly, Timothy R. Kane, Bret M. Benton, Tiffany R. Keepers, Mariana Castanheira, Dmitri Debabov, Koné Kaniga, Wright W. Nichols and Deborah L. Higgins. Their work appears in journals such as New England Journal of Medicine, Journal of the American Chemical Society and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.